This validated ML tool integrates meta-evidence with clinical data for early, accurate IPA risk stratification in immunocompetent patients. It effectively captures nonlinear predictor interactions and demonstrates strong generalizability, supporting clinical utility.
Liu et al. (Thu,) studied this question.